News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Gerry Hanna: ESMO-ESTRO Framework for Radiotherapy and Systemic Therapy Safety
Gerry Hanna/X
Jun 14, 2025, 03:27

Gerry Hanna: ESMO-ESTRO Framework for Radiotherapy and Systemic Therapy Safety

Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, posted on X:

“In this month’s Radiotherapy and Oncology Journal Van Aken, et al describe a framework to assess interactions and safety of targeted therapies or Immunotherapy combinations with Radiotherapy.
Pragmatic and biologically informed guidance on how to address.”

Title: ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy

Authors: Evert S.M. van Aken, Bharti Devnani, Luis Castelo-Branco, Dirk De Ruysscher, Diogo Martins-Branco, Corrie A.M. Marijnen, Barbara Muoio, Claus Belka, Florian Lordick, Stephanie Kroeze, George Pentheroudakis, Dario Trapani, Umberto Ricardi, Ajeet Kumar Gandhi, Arsela Prelaj, Sean M. O’Cathail, Monique C. de Jong

Read The Full Article at Radiotherapy and Oncology Journal.

Gerry Hanna: ESMO-ESTRO Framework for Radiotherapy and Systemic Therapy Safety

More posts featuring Gerry Hanna.

Ajeet Kumar Gandhi Arsela Prelaj Barbara Muoio Bharti Devnani Claus Belka Corrie A.M. Marijnen Dario Trapani Diogo Martins Branco Dirk de Ruysscher Florian Lordick George Pentheroudakis Gerry Hanna immunotherapy Luis Castelo-Branco Monique C. de Jong radiotherapy Radiotherapy and Oncology Journal Sean M. O’Cathail Stephanie Kroeze Umberto Ricardi Van Aken
Special Coverage
Oncolibrary
Jul 3, 2025, 12:18
Glioblastoma Cure Rate: What Patients Should Know
Blog
Jul 3, 2025, 12:15
Nutrition Isn’t Just Supportive Care, It’s a Core Part of Cancer Treatment - SPCC
Oncolibrary
Jul 3, 2025, 12:01
CONTACT-02 Trial 2025 Update: Atezolizumab Plus Cabozantinib in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Insight
Jul 3, 2025, 11:56
Updates from the ESMO Gastrointestinal Cancers Congress 2025
Career
Jul 3, 2025, 11:43
Dan Milner: I’m Beginning as the Chief of Pathology at Olive View-UCLA Hospital in Sylmar
Science
Jul 3, 2025, 11:29
Myeloma Paper of the Day, July 3rd, Suggested by Robert Orlowski
Stories
Jul 3, 2025, 10:58
A Reminder That Clinical Trials Don’t Just Offer Hope - They Offer the Chance to Live - Sylvester Comprehensive Cancer Center
Societies
Jul 3, 2025, 10:55
ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care
Science
Jul 3, 2025, 10:46
Wafik El-Deiry: Collaborative Manuscript by Jim Abraham et al. Colleagues at Caris Life Sciences and the Caris Precision Oncology Alliance
Blog
Jul 3, 2025, 10:33
Dana-Farber Cancer Institute Welcomed Delegation From the Kingdom of Saudi Arabia Ministry of Health
Blog
Jul 3, 2025, 10:25
CancerWorld - Meet Albertina, the Changemaker of Cancer Journalism
Blog
Jul 3, 2025, 10:24
IARC and American Cancer Society Launch The Cancer Atlas, Fourth Edition